The incidence of type 2 diabetes continues to increase at epidemic proportions, 1 while vascular and renal diabetic complications have huge socioeconomic consequences. The etiology of this disease is multifactorial and an increasing amount of evidence points to environmental and lifestyle factors rather than genetic abnormalities as the most important predisposing factors. 2, 3 Type 2 diabetes is often accompanied by obesity and is characterized by inflammation and insulin resistance (IR), both of which are attributed to increased oxidant stress (OS).
Impact of Advanced Glycation End-products on Insulin Secreting and Insulin Sensitive Tissues
A large body of literature points to the multiorgan injury caused by AGEs, implicating them in most complications associated with diabetes. 2, [9] [10] [11] However, other studies have began to suggest that AGEs are involved in islet β-cell damage: aminoguanidine (AG), which inhibits the formation of AGEs, 23 protected islet β-cell function in vivo 24 as well as in isolated rat islets. 24, 25 Restriction of orally absorbed AGEs significantly protected pancreatic islet morphology and/or function in four models of diabetes: mice susceptible to autoimmune type 1 diabetes (in NOD mice) or to type 2 diabetes (db/db+/+ mice) 13, 14 (see Figure 1) , as well as fat-induced or age-related diabetes. 15, 17 Recent evidence affirmed these findings and assigned AGE-mediated β-cell toxicity to the inhibition of cytochrome-c oxidase and adenosine triphosphate (ATP) production, causing impaired insulin secretion. 12, 24, 25 These studies began to fill in some of the conceptual gaps on the potential sources and mechanisms by which pre-existing oxidant overload can lead to β-cell insufficiency and damage.
Other findings shed more light at the other end of glucose-insulin interactions, supporting AGEs as the cause of reduced peripheral insulin responsiveness and glucose utilization. Studies in adipocytes or mice, exposed to specific AGEs, showed that glycoxidants can lead to a decrease in insulin receptor and insulin-receptor substrate 1 (IRS-1) phosphorylation levels, consequently impairing glucose-uptake, via Jun N-terminal kinase (JNK) activation. 26 These findings have began to shift previously held views and to introduce the notion that prolonged exposure to oxidant overload-possibly spanning several generations-can deplete innate immune defense and foster defective insulin action, a possibility that has begun to receive support in the clinical setting. 18, 21, 26 Exogenous Sources of Advanced Glycation End-products-A New Cause of Diabetes?
AGEs are readily introduced into the circulation of the human body with nutrients 27 or tobacco smoking 28 long before, or in the absence of diabetes. Certain methods of food processing, particularly heat and dehydration, significantly accelerate the generation of new highly reactive dicarbonyl derivatives of complex glyco-and lipoxidation reactions. 29, 30 Approximately 10% of AGEs in a single AGE-rich meal are absorbed into the circulation, and two-thirds are still in the body seven hours later, 31 an interval sufficient to promote tissue injury. AGEs such as CML, MG-derivatives, and others are potent inducers of inflammation. 30, 32, 33 As the effects of either exogenous or endogenous AGEs can be blocked by both antioxidants and anti-AGE agents, 23, 30, 32 they in fact have a full range of overlapping biological properties (see Figure 2) . The daily intake of AGEs with regular meals (e.g. of non-excessive caloric content) by healthy adults is estimated to exceed the 'safe' range by at least two to three times, 34 related largely to the fact that the preferred methods of food preparation by the average US adult promote the AGE overload. This may also account for the alarming recent finding that high serum AGE levels in mothers correlated with those of their infants and predicted higher plasma insulin levels or homeostatic model assessment (HOMA) and lower adiponectin, 35 factors that may pre-condition infants to high OS and, possibly, to diabetes.
Two large databases containing the AGE content of common foods have been made available. 34, 36 These illustrate how dry heat-processing methods (such as broiling, searing, or frying) significantly increase the protein-and lipid-AGE content of foods compared with methods that utilize lower temperatures and moisture (i.e. stewing, steaming, or boiling; see Table 1 ) and how the same amount or type of nutrients, i.e. of fats can deliver dramatically different amounts of oxidant substances, which may also promote antigenic stimulation. These databases helped in the development of tools for assessing dietary AGE intake, as well as for adjusting diets to a lower AGE content, while maintaining optimal caloric and nutrient intake. Given to subjects with or without diabetes or with chronic kidney disease, a low AGE dietary regimen proved highly effective in lowering circulating AGEs, inflammation, and IR. 21, 26 This intervention, if confirmed, may represent a significant advance toward the prevention of type 2 diabetes, or the improved efficacy of diabetes therapies.
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Humans and Food Advanced Glycation End-products
Significantly lower levels of serum AGEs were observed in patients (with type 1 and type 2 diabetes, after six weeks on a low-AGE American
Diabetes Association (ADA)-recommended diet. 37 This and several other studies demonstrated that the diet is a significant source of AGEs for humans and that orally absorbed AGEs directly affect serum AGE levels, and therefore, oxidant-antioxidant balance in patients with type 2 diabetes. Prior to these studies, elevated AGE levels in patients with type 2 diabetes had been attributed to endogenous sources, especially hyperglycemia and OS. 9 In pursuing the origin of elevated OS further, it was noted that people without diabetes who consumed a diet with a high AGE content had levels of serum AGEs associated with diabetes and higher OS compared with those consuming a diet with a lower AGE content. 18, 21 Contrary to previous belief, serum AGEs were found to be independent of age, but correlated with established markers of OS and inflammation. 18, 21 In addition, there was a significant association between serum AGEs and HOMA, an indicator of IR, in healthy subjects. Importantly, consumed AGEs (but not calories, nutrients, glucose, or lipids) proved to be independent predictors of serum AGEs and high-sensitivity C-reactive protein (hsCRP), a prototypic marker of inflammation. These data suggested that the common diet is a significant source of oxidants in people without diabetes or in a pre-diabetic state.
This may be of particular concern today since many 'healthy' subjects with a normal body mass index (BMI) tend to consume diets with excessive glycoxidants and may thus be at risk for type 2 diabetes. Figure 3) . The balance between these two receptors may be critical in the maintenance of oxidant homeostasis or progression to diabetes. Recent evidence suggests that AGER1 also acts to protect sirtuin (silent mating type information regulation 2 homolog) 1 (SIRT1), a major deacetylase and regulator of inflammation and insulin actions. SIRT1, similar to AGER1, is suppressed in chronic diabetes, but restored after lowering external oxidant burden by AGE restriction. The Importance of Anti-advanced Glycation End-product Receptors
Advanced Glycation End-product Metabolism
In healthy subjects, ambient levels of AGEs and ROS drive the expression of both AGER1 and RAGE. A short-term increase in AGEs is associated with an increase in RAGE, as well as in AGER1, which maintains the oxidative balance within cells. Similarly, consumption of a low-AGE diet by healthy subjects effectively lowers both AGER1 and RAGE levels. While further studies are necessary, from these studies, one message is that under these conditions decisive headway may be gained only by restraining the currently unregulated entry of exogenous oxidants.
Another message is that innate immune defenses and antioxidants may be rapidly bolstered after reducing the external oxidant load, rather than by continuing to increase the dosages of perfectly functional but inadequate oral antioxidants.
Clinical Studies in Diabetes and Advanced Glycation End-product Toxicity
There is considerable support for the role of AGEs in human diabetes, as well as for non-diabetic CVD or renal disease. [47] [48] [49] [50] [51] A significant correlation was previously found between circulating AGE-apolipoprotein B (apoB) levels, vascular tissue AGEs, and severity of atherosclerotic lesions in patients without diabetes with coronary artery occlusive disease, 48 and in patients with diabetes with aortic stiffness. 50 Serum pentosidine has also been shown to correlate positively with heart-brachial pulse wave velocity and with carotid intima-media thickness 52 in patients with type 2 diabetes. In a random sample of Finnish patients with type 2 diabetes followed for 18 years, serum levels of AGEs were associated with total and CVD mortality in women. 22 These studies reinforce the role of AGEs in diabetic complications, apart from that of hyperglycemia.
Moreover, the concept that nutrient-derived oxidant AGEs could pose risk for acquiring diabetes-not only for diabetic vascular disease-has introduced a paradigm shift, according to which hyperglycemia could be the downstream effect, not the cause of high AGEs and thus, glucose control is but one variable that must be controlled (see Figure 4) . and BMI in patients with type 2 diabetes (see Figure 5 ). 26 After a longer treatment interval of such patients with an AGE-restricted diet (four months), there was a significant reduction in plasma insulin, as well as in leptin, along with a marked rise in adiponectin. These changes were consistent with an improvement in insulin sensitivity in these patients with diabetes, who had persistent IR despite medical treatment. There were also a significant increase in AGER1 and SIRT1 levels and reduced nuclear factor-kappa B (NFκB) activity, based on decreased mononuclear TNF-α, all consistent with suppressed inflammation in these subjects. Of note, this was the first study to show a dramatic reduction in RAGE levels (~50-60%) below baseline.
These findings await confirmation in larger trials. Since they were independent of other changes in medical therapy, they strongly support the postulate that it is the externally derived pro-inflammatory AGEs that drive inflammation and IR to a large extent. 21, 26 They also show that
The 
Serum advanced glycation end-products (AGE) correlate with fasting plasma insulin (A), homeostatic model assessment insulin resistance (HOMA-IR) (B), and body mass index (BMI) (C). Serum AGEs carboxymethyllysine (CML) or methylglyoxal (MG)-derivatives were assessed by enzyme-linked immunosorbent assays (ELISAs
Strategies to Reduce Dietary Advanced Glycation End-products
After consuming a meal with high AGE content, healthy adults show a rapid absorption of AGEs, with a rapidly rising peak in serum AGE level.
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A close correlation was observed between AGEs consumed and AGEs in the circulation in a cross-section of healthy subjects. 18 In addition, 
Conclusions
There is little controversy surrounding the fact that AGEs contribute significantly to OS and inflammation in diabetes and complications associated with diabetes. Endogenous hyperglycemia is a significant driving force for the generation of AGEs, but this can be substantially greater, since it is built on a premise of already elevated or pre-existing overt OS. It is becoming increasingly clear that the common diet is a carrier of AGEs and, thus, is a major contributor to basal OS, which impairs innate immune defenses and drives IR. This causal factor is of particular concern in subjects not only with diabetes but also with pre-diabetes. Thus, AGE overload as a cause of diabetes is an area of major clinical relevance. While many pharmacologic anti-AGE therapies are under development, their efficacy remains to be proved. In the interim, interventions that reduce both exogenous (food-derived) as well as endogenous (hyperglycemia-derived) AGEs can provide definitive and lasting beneficial effects for diabetes and its complications. n Diabetes Pathophysiology 18
